BioNTech SE (BNTX) Common Equity (2018 - 2026)
BioNTech SE (BNTX) reported Common Equity of $20.64 billion for Q2 2026, down 1.5% from $20.95 billion a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, BioNTech SE posted Common Equity of $22.38 billion, up 7.9% from FY2024.
- Common Equity has a five-year compound annual growth rate of 70.2% (FY2020 to FY2025).
- By year, Common Equity came in at $20.74 billion in FY2024 (-4.8%), $21.78 billion in FY2023 (+6.5%), $20.46 billion in FY2022 (+50.4%) and $13.61 billion in FY2021 (+768.7%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q1 2025.
- Year over year, Common Equity gained in four of the last eight quarters, with growth averaging 0.7%.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 848.1%); the low point was Q1 2025 (a decline of 8.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $21.89 billion (Q1 2026), $22.38 billion (Q4 2025) and $21.6 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn | 20.64 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.64 Bn |
| Mar 31, 2026 | 21.89 Bn |
| Dec 31, 2025 | 22.38 Bn |
| Sep 30, 2025 | 21.60 Bn |
| Jun 30, 2025 | 20.95 Bn |
| Mar 31, 2025 | 19.91 Bn |
| Dec 31, 2024 | 20.74 Bn |
| Sep 30, 2024 | 20.99 Bn |
| Jun 30, 2024 | 20.54 Bn |
| Mar 31, 2024 | 21.69 Bn |
| Dec 31, 2023 | 21.78 Bn |
| Sep 30, 2023 | 21.63 Bn |
| Jun 30, 2023 | 21.68 Bn |
| Mar 31, 2023 | 21.75 Bn |
| Dec 31, 2022 | 20.46 Bn |
| Sep 30, 2022 | 18.52 Bn |
| Jun 30, 2022 | 17.96 Bn |
| Mar 31, 2022 | 17.86 Bn |
| Dec 31, 2021 | 13.61 Bn |
| Sep 30, 2021 | 10.27 Bn |
API Access
BioNTech SE Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();